Evidence map›Paper›PMID 40330080›Full record

ArticleHead and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings2025

Head and Neck Tumor Segmentation Using Pre-RT MRI Scans and Cascaded DualUNet.

Mikko Saukkoriipi, Jaakko Sahlsten, Joel Jaskari, Ahmed Al-Tahmeesschi, Laura Ruotsalainen, Kimmo Kaski

Abstract read
In one paragraph

Article in Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Overview of the Head and Neck Tumor Segmentation for Magnetic Resonance Guided Applications (HNTS-MRG) 2024 Challenge.Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mikko SaukkoriipiDepartment of Computer Science, Aalto University, Espoo, Finland.
Jaakko SahlstenDepartment of Computer Science, Aalto University, Espoo, Finland.
Joel JaskariDepartment of Computer Science, Aalto University, Espoo, Finland.
Ahmed Al-TahmeesschiDepartment of Electronic Engineering, University of York, York, UK.
Laura RuotsalainenDepartment of Computer Science, University of Helsinki, Helsinki, Finland.
Kimmo KaskiDepartment of Computer Science, Aalto University, Espoo, Finland.

Funding

Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac deviceR01DE028290 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHRISTODOULEAS, JOHN PAUL, FULLER, CLIFTON DAVID · 2019 to 2023
$4.3M
SCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head & Neck CancerR01CA257814 · NCI · RICE UNIVERSITY · PI FULLER, CLIFTON DAVID, SCHAEFER, ANDREW J · 2021 to 2024
$1.8M
NCI NIH HHS R01 CA257814NIDCR NIH HHS R01 DE028290
6 · The paper itself

Abstract

Accurate segmentation of the primary gross tumor volumes and metastatic lymph nodes in head and neck cancer is crucial for radiotherapy but remains challenging due to high interobserver variability, highlighting a need for an effective auto-segmentation tool. Tumor delineation is used throughout radiotherapy for treatment planning, initially for pre-radiotherapy (pre-RT) MRI scans followed-up by mid-radiotherapy (mid-RT) during the treatment. For the pre-RT task, we propose a dual-stage 3D UNet approach using cascaded neural networks for progressive accuracy refinement. The first-stage models produce an initial binary segmentation, which is then refined with an ensemble of second-stage models for a multiclass segmentation. In Head and Neck Tumor Segmentation for MR-Guided Applications (HNTS-MRG) 2024 Task 1, we utilize a dataset consisting of pre-RT and mid-RT T2-weighted MRI scans. The method is trained using 5-fold cross-validation and evaluated as an ensemble of five coarse models and ten refinement models. Our approach (team FinoxyAI) achieves a mean aggregated Dice similarity coefficient of 0.737 on the test set. Moreover, with this metric, our dual-stage approach highlights consistent improvement in segmentation performance across all folds compared to a single-stage segmentation method.

Indexed as

3D UNetCascaded deep neural networksDual-stage refinementHNTS-MRGMRI Head and Neck Tumor Segmentation

Identifiers

PMID40330080
PMCPMC12050416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.